The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies.

Saved in:
Bibliographic Details
Title: The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies.
Authors: Nordon C; Biopharmaceuticals Medical, AstraZeneca, Cambridge, UK., Simons SO; Department of Respiratory Medicine, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands., Marshall J; Biopharmaceuticals Medical, AstraZeneca, Cambridge, UK., Müllerová H; Biopharmaceuticals Medical, AstraZeneca, Cambridge, UK., Pollack M; Biopharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA., Bengtsson C; IQVIA, Solna, Sweden., Hoti F; IQVIA, Espoo, Finland., Lobier M; IQVIA, Espoo, Finland., Salosensaari A; IQVIA, Turku, Finland., Santos AC; IQVIA, Oeiras, Portugal., Vogelmeier CF; Pulmonary and Critical Care Medicine, German Center for Lung Research, Marburg, Germany., Rhodes K; Biopharmaceuticals Medical, AstraZeneca, Cambridge, UK.
Source: ERJ open research [ERJ Open Res] 2025 Jun 16; Vol. 11 (3). Date of Electronic Publication: 2025 Jun 16 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2312-0541
DOI:10.1183/23120541.01091-2024